These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 214233)

  • 1. [The role of low-density lipoprotein in the pathogenesis of atherosclerosis].
    Zák A; Rublicová J; Skorepa J
    Cas Lek Cesk; 1978 Oct; 117(42):1305-10. PubMed ID: 214233
    [No Abstract]   [Full Text] [Related]  

  • 2. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
    Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
    J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperlipoproteinemia and its role in the pathogenesis of arteriosclerosis].
    Klimov AN
    Patol Fiziol Eksp Ter; 1972; 16(5):3-12. PubMed ID: 4363573
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenetic importance of prostacyclin in atherosclerosis].
    Efimov VV; Ladnyĭ AI
    Ter Arkh; 1985; 57(9):142-8. PubMed ID: 3909478
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis.
    Ozer NK; Boscoboinik D; Azzi A
    Biochem Mol Biol Int; 1995 Jan; 35(1):117-24. PubMed ID: 7735126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis.
    Chait A
    West J Med; 1994 Feb; 160(2):183-4. PubMed ID: 8160476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of intrinsic low density lipoprotein in the vascular wall. Significance for the pathogenesis of essential hypertension and arteriosclerosis].
    Sachinidis A; Ko Y; Vetter W; Vetter H
    Med Klin (Munich); 1994 Dec; 89(12):662-7. PubMed ID: 7870001
    [No Abstract]   [Full Text] [Related]  

  • 10. Underlying mechanisms in atherosclerosis.
    Steinberg D
    J Pathol; 1981 Jan; 133(1):75-87. PubMed ID: 7009813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins, cholesterol ester transport and atherogenesis.
    Eisenberg S
    Monogr Atheroscler; 1986; 14():107-12. PubMed ID: 3736547
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of lipoprotein on phosphatidylinositol -4,5-bisphosphate and phosphatidic acid in platelet].
    Huang RS; Wang Z
    Zhonghua Yi Xue Za Zhi; 1993 Feb; 73(2):85-7, 126. PubMed ID: 8391903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein-dependent synthesis of prostacyclin in smooth muscle cells].
    Shakhov IuA; Dorian B; Daret D; Desgranges C; Shcherbakova IA
    Biokhimiia; 1988 Jan; 53(1):118-25. PubMed ID: 3129034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of atherosclerosis. Contribution from a cytobiological viewpoint].
    Baumgartner HR
    Schweiz Med Wochenschr; 1977 May; 107(21):717-22. PubMed ID: 559346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current data on the pathogenesis of atherosclerosis].
    Nicolaescu V; Cerchez T
    Med Interna (Bucur); 1971 Mar; 23(3):303-12. PubMed ID: 5574927
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of experimental models for the development of clinical trials on thromboatherosclerosis.
    Fuster V; Ip JH; Badimon L; Badimon JJ; Stein B; Chesebro JH
    Circulation; 1991 Jun; 83(6 Suppl):IV15-25. PubMed ID: 1645625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of lipoproteins on signal transduction in thrombocytes and vascular wall cells].
    Bochkov VN; Tkachuk VA
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):12-30. PubMed ID: 15773577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of atherosclerosis.
    Gorlin R
    Major Probl Intern Med; 1976; 11():29-39. PubMed ID: 185471
    [No Abstract]   [Full Text] [Related]  

  • 19. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
    Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
    Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vasoprotective and vasoaggressive characteristics of serum lipoproteins].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Dec; 120(50):1671-2. PubMed ID: 214704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.